On-Treatment NLR Dynamics During CDK4/6 Inhibition Are Associated with Overall Survival in Metastatic Breast Cancer.

Kisqali (ribociclib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42738414

Ahmad Khater; Anas Zayed; Baha Sharaf; Faris Tamimi; Maen Hamad; Nader Obeidat; Qasem Alzoubi; Sharif Jehad; Zaid Omari

Sep 16, 2026